دورية أكاديمية

The Influence of Obesity on Outcomes with Immune Checkpoint Blockade: Clinical Evidence and Potential Biological Mechanisms.

التفاصيل البيبلوغرافية
العنوان: The Influence of Obesity on Outcomes with Immune Checkpoint Blockade: Clinical Evidence and Potential Biological Mechanisms.
المؤلفون: Hahn, Andrew W.1 (AUTHOR) ahahn@mdanderson.org, Venkatesh, Neha2 (AUTHOR), Msaouel, Pavlos1,3,4 (AUTHOR), McQuade, Jennifer L.5 (AUTHOR) ahahn@mdanderson.org
المصدر: Cells (2073-4409). Nov2023, Vol. 12 Issue 21, p2551. 14p.
مصطلحات موضوعية: *OBESITY paradox, *IMMUNE checkpoint proteins, *OBESITY, *BODY mass index, *BODY composition, *IMMUNOCOMPUTERS
مستخلص: Immune checkpoint blockade (ICB) is a mainstay of treatment for advanced cancer, yet tumor response and host toxicity are heterogenous in those patients who receive ICB. There is growing interest in understanding how host factors interact with tumor intrinsic properties and the tumor microenvironment to influence the therapeutic index with ICB. Obesity, defined by body mass index, is a host factor associated with improved outcomes in select cancers when treated with ICB. While the biological mechanism for this obesity paradox is not fully understood, pre-clinical and translational studies suggest obesity may potentially impact tumor metabolism, inflammation, and angiogenesis. Herein, we summarize clinical studies that support an obesity paradox with ICB, explore potential biological mechanisms that may account for the obesity paradox, and address methodological challenges to consider when studying obesity and treatment outcomes. [ABSTRACT FROM AUTHOR]
قاعدة البيانات: Academic Search Index
الوصف
تدمد:20734409
DOI:10.3390/cells12212551